Abdominoperineal Resection (APR) for Rectal Cancer: Indications
APR is indicated for distal rectal adenocarcinomas when sphincter-sparing surgery is not feasible—specifically when the tumor involves the anal sphincter complex, levator muscles, or when adequate distal margins cannot be achieved while preserving sphincter function. 1
Primary Indications for APR
The decision to perform APR versus sphincter-sparing surgery depends on specific anatomic and oncologic factors:
Anatomic Criteria
- Tumor location: Distal tumors requiring sphincter sacrifice for adequate oncologic resection
- Sphincter involvement: Direct invasion of the internal or external anal sphincter
- Levator muscle involvement: Tumors extending into the pelvic floor musculature
- Inadequate distal margin: When a 1-2 cm distal margin cannot be achieved with sphincter preservation
Patient-Specific Factors
- Baseline sphincter function: Pre-existing fecal incontinence may favor APR over a poorly functioning anastomosis
- Patient anatomy: Body habitus, narrow pelvis, or bulky tumors in male patients may preclude safe low anastomosis
- Patient preference: After informed discussion about permanent colostomy versus risk of poor functional outcomes with ultra-low anastomosis
Important Caveats and Modern Considerations
The threshold for APR has decreased substantially with modern neoadjuvant therapy. 2 The GRECCAR 1 trial demonstrated that 85% of ultra-low rectal cancers initially designated for APR could be converted to sphincter-saving surgery after neoadjuvant treatment, with excellent 10-year oncologic outcomes (OS 72.2% for sphincter-saving vs 54.7% for APR) 2.
Exclusion Criteria from PROSPECT Trial 3
APR was specifically excluded for patients with:
- cT2N1, cT3N0, or cT3N1 tumors amenable to sphincter-sparing surgery at baseline
- Mid or high rectal tumors (>5 cm from anal verge)
This indicates that APR should be reserved for truly distal tumors where sphincter preservation is anatomically impossible, not simply because of tumor stage.
Surgical Technique Variations
When APR is necessary, three technical approaches exist 4:
- Extralevator APR: Wider excision including levator muscles—preferred for tumors involving or close to the levator plate to reduce circumferential margin positivity
- Extrasphincteric APR: Standard approach with sphincter complex removal
- Intersphincteric APR: More conservative, rarely used for cancer
Extralevator APR has reduced specimen perforation and local recurrence rates compared to standard APR 5, and should be considered the default technique when APR is required.
Organ-Preservation Alternatives
Before committing to APR, consider response-adapted strategies:
- Total neoadjuvant therapy (TNT) with induction chemotherapy followed by chemoradiotherapy is now the predominant approach in expert centers 6, particularly for low rectal cancers
- Watch-and-wait approach: For patients achieving complete clinical response after neoadjuvant therapy, non-operative management is increasingly accepted 7
- Local excision techniques: ESD or transanal approaches may be appropriate for select T1N0 tumors 1, though understaging is common and requires careful patient selection
Common Pitfalls to Avoid
- Premature decision-making: Do not commit to APR before completing neoadjuvant therapy and reassessing tumor response 2
- Inadequate staging: Thorough MRI evaluation of mesorectal fascia involvement and sphincter complex is essential before surgical planning 1
- Ignoring functional outcomes: APR carries significant quality-of-life implications; shared decision-making is critical when sphincter-saving options exist 4
Bottom line: APR remains necessary for distal rectal cancers with sphincter involvement, but modern neoadjuvant strategies have dramatically reduced its frequency—reassessment after total neoadjuvant therapy often reveals sphincter-sparing options that were not initially apparent.